Because the lasting time of remission (LTR) can directly reflect the prognosis for IBD patients,[39] and because the patients with complicated CD had a significant shorter LTR than the control subjects, we therefore performed an ROC analysis between the CD8+CD28+/CD8+CD28– ratio and the LTR. The gene discussed is CD8A; the disease is inflammatory bowel disease.